Last reviewed · How we verify
NCT05134389
Survey on GI and Nutritional Parameters Among OAGB Patients From Different Countries
trial testing One Anastomosis Gastric Bypass in Obesity in 493 participants. Completed in 1 November 2021.
18 May 2021
Quick facts
| Lead sponsor | Assuta Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 493 |
| Start date | 18 May 2020 |
| Primary completion | 18 May 2021 |
| Estimated completion | 1 November 2021 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- One Anastomosis Gastric Bypass
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Assuta Medical Center
Who can join
18 and older, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
One Anastomosis Gastric Bypass (OAGB) surgery is a type of bariatric surgery (BS) which is gaining popularity worldwide and is considered to be a simple, safe and effective bariatric procedure in terms of weight loss and comorbidities resolution. However, only limited data exists on the nutritional and gastrointestinal (GI) consequences of this procedure. This study aimed to gain information on GI and nutritional parameters from a large sample of OAGB patients living in 3 different countries. Post-OAGB patients across Israel (n=277), Spain (n=105) and Portugal (n=111) were recruited to the study based on the time elapsed since surgery \[1-6 months (1-6M), 6-12 months (6-12M) and 1-5 years (1-5Y) post-surgery\]. Participants were asked to complete an anonymous survey delivered by SurveyMonkey®️ software which included data on demographics, comorbidities, anthropometrics, GI outcomes and satisfaction with the procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05134389
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of One Anastomosis Gastric Bypass
Trials testing the same drug.
- NCT06970093 — Comparison of One Anastomisis Gastric Bypass and Duodeno-Jejunostomy for Treating SMA Syndrome · NA · completed
- NCT05481853 — One Anastomosis Gastric Bypass for Severe Obesity in 6,722 Patients: Early Outcomes From the Assuta Surgery Registry · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Assuta Medical Center trials
Trials by the same sponsor.
- NCT06950684 — Impact of Protein Supplementation and Resistance Training on Body Composition, Functional Parameters, Metabolic Adaptati · NA · not yet recruiting
- NCT05122013 — Remote Intervention for Weight Regain After Sleeve Gastrectomy · NA · completed
- NCT04741113 — The Effect of an Education Module to Reduce Weight Bias Among Healthcare Professionals in a Private Hospital Setting · NA · completed
- NCT04451499 — The Effect of Adding Smartphone-based Platform to the Bariatric Surgery Preparation Process · NA · completed
- NCT03389204 — Upper Limb Function After Breast Cancer Surgery: the Role of Post-operative Physical Therapy Intervention · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05134389 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assuta Medical Center
- Last refreshed: 30 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05134389.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing